Abstract
Purpose
A primary operative complication of radical hysterectomy for cervical cancer is hemorrhage. Intraoperative autologous blood transfusion (ABT) may be beneficial in reducing the need for homologous blood transfusion.
Methods
Our institution published a prospective cohort study examining the use of ABT in cervical cancer patients undergoing radical hysterectomy in 1995. Patients who were initially consented to participate in this prospective trial using intraoperative ABT (cell saver) were evaluated with a median follow-up of 3 years. We sought to update this original report with 16-year follow-up data collected from the clinical charts, Tumor Registry, and the Social Security Death Index.
Results
Two groups of patients undergoing radical hysterectomy were compared: patients who received ABT, and those who did not. Of the 71 original patients, all were included in this updated review, with an average follow-up of 12.4 years for both groups. Originally, thirty-one patients received an ABT. In this group, 1 patient was lost to follow-up, and 4 (12.9 %) are deceased including 1 (3 %) with disease. In the non-autologous group, there were 7 (17.5 %) patient deaths, including 3 (7.5 %) with disease. Eighty-three percent were alive after 12 years in both groups. The ABT group had 1 patient (3 %) who developed a secondary malignancy, a colon adenocarcinoma. The non-autologous group had 2 patients (5 %) who developed a secondary malignancy; one patient developed multiple myeloma and one patient developed a verrucous cancer of the tongue.
Conclusions
Autologous blood transfusion during radical hysterectomy for cervical cancer appears safe and effective.
Similar content being viewed by others
References
(1986) Autologous blood transfusions. Council on Scientific Affairs. JAMA 256(17):2378–2380
(2008) Intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy: guidance. National Institute for Health and Clinical Excellence (NICE), No N1551, London
Amato A, Pescatori M (2006) Perioperative blood transfusion for the recurrence of colorectal cancer. Cochrane Database Syst Rev 1:CD005033
Azuma C, Koyama M, Inagaki M, Ito S, Sawada M, Saji F, Ozaki M (1997) The influence of peri-operative blood transfusion during radical hysterectomy on the prognosis of uterine cervical cancer. Transfus Sci 18(1):55–62
Benjamin I, Barakat RR, Curtin JP, Jones WB, Lewis JL Jr, Hoskins WJ (1994) Blood transfusion for radical hysterectomy before and after the discovery of transfusion-related human immunodeficiency virus infection. Obstet Gynecol 84(6):974–978
Blumberg N, Agarwal MM, Chuang C (1988) A possible association between survival time and transfusion in cervical cancer. Yale J Biol Med 61(6):493–500
Blumberg N, Heal JM (1987) Perioperative blood transfusion and solid tumour recurrence. Blood Rev 1(4):219
Brander L, Reil A, Bux J, Taleghani BM, Regli B, Takala J (2005) Severe transfusion-related acute lung injury. Anesth Analg 101(2):499–501
Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA (2010) Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (3):CD001888
Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L (2008) Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 63(12):1332–1338
Connor JP, Morris PC, Alagoz T, Anderson B, Bottles K, Buller RE (1995) Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol 86(3):373–378
Duffy G, Neal KR (1996) Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies. Transfus Med 6(4):325–328
Estape R, Lambrou N, Diaz R, Estape E, Dunkin N, Rivera A (2009) A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy. Gynecol Oncol 113(3):357–361
Fanning J, Fenton B, Purohit M (2008) Robotic radical hysterectomy. Am J Obstet Gynecol 198(6):649.e1–649.e4
Hanprasertpong J, Chichareon S, Wootipoom V, Buhachat R, Tassee S, Geater A (2007) Lack of effect of perioperative blood transfusion during radical hysterectomy with lymph node dissection on the prognosis of cervical cancer stage Ib. Asian Pac J Cancer Prev 8(4):476–480
Heal JM, Chuang C, Blumberg N (1988) Perioperative blood transfusions and prostate cancer recurrence and survival. Am J Surg 156(5):374–380
Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W (2005) Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 45(1):103–110
Magrina JF, Kho RM, Weaver AL, Montero RP, Magtibay PM (2008) Robotic radical hysterectomy: comparison with laparoscopy and laparotomy. Gynecol Oncol 109(1):86–91
Mirhashemi R, Averette HE, Deepika K, Estape R, Angioli R, Martin J, Rodriguez M, Penalver MA (1999) The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. Am J Obstet Gynecol 181(6):1310–1315 discussion 1315–1316
Monk BJ, Tewari K, Gamboa-Vujicic G, Burger RA, Manetta A, Berman ML (1995) Does perioperative blood transfusion affect survival in patients with cervical cancer treated with radical hysterectomy? Obstet Gynecol 85(3):343–348
Morris PC, Haugen J, Tomjack J, Anderson B, Buller RE (1995) Blood transfusion and the risk of recurrence in stage IB cervical cancer. Gynecol Oncol 57(3):401–406
Nam JH, Park JY, Kim DY, Kim JH, Kim YM, Kim YT (2011) Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol 22:59–67
Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (eds). (2007) SEER survival monograph: cancer survival among adults: U.S. SEER program, 1988–2001, patient and tumor characteristics. National Cancer Institute, SEER Program, NIH Pub No 07-6215
Soper JT, Berchuck A, Clarke-Pearson DL (1991) The clinical significance of blood transfusion at the time of radical hysterectomy. Obstet Gynecol 77(1):165–166
Spiess BD, Ley C, Body SC, Siegel LC, Stover EP, Maddi R, D’Ambra M, Jain U, Liu F, Herskowitz A, Mangano DT, Levin J (1998) Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg 116(3):460–467
Surgenor SD, DeFoe GR, Fillinger MP, Likosky DS, Groom RC, Clark C, Helm RE, Kramer RS, Leavitt BJ, Klemperer JD, Krumholz CF, Westbrook BM, Galatis DJ, Frumiento C, Ross CS, Olmstead EM, O’Connor GT (2006) Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 114(1 Suppl):I43–I48
Tinelli R, Malzoni M, Cosentino F, Perone C, Fusco A, Cicinelli E, Nezhat F (2011) Robotics versus laparoscopic radical hysterectomy with lymphadenectomy in patients with early cervical cancer: a multicenter study. Annals Surg Oncol 18(9):1–7
Waters JH, Sprung J (2001) Errors during intraoperative cell salvage because of inappropriate wash solutions. Anesth Analg 93(6):1483–1485
WHO (2007) Cervical cancer, human papillomavirus (HPV), and HPV vaccines—key points for policy-makers and health professionals, 1st edn. World Health Organization, Geneva
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Engle, D.B., Connor, J.P., Morris, P.C. et al. Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: long-term follow-up of a prospective trial. Arch Gynecol Obstet 286, 717–721 (2012). https://doi.org/10.1007/s00404-012-2351-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-012-2351-1